Advances in Cancer Detection and Treatment
Nearly 500 Students Participate in Annual Cake Wars Competition to Raise Funds for Breast Cancer Awareness On February 4, nearly 500 students gathered in Furst Hall on the Wilf Campus to participate in one of the most popular events of the year, the Fifth Annual YU Sharsheret Cake Wars Competition. The event raises money for […]
Dr. Marina Holz, assistant professor of biology at Yeshiva University’s Stern College for Women, was recently awarded a one-year $30,000 grant from the Wendy Will Case Cancer Fund to research the role of the mTOR (mammalian target of rapamycin) /S6 Kinase 1 (S6K1) genetic pathway in breast cancer.
Dr. Marina Holz, assistant professor of biology at Yeshiva University’s Stern College for Women, is leading the charge in the fight against breast cancer. After receiving a $75,000 grant from the Elias Genevieve and Georgiana Atol Charitable Trust to research the molecular mechanisms of the S6 Kinase 1 (S6K1) gene, Holz was recently awarded a one-year $30,000 grant from the Wendy Will Case Cancer Fund to research the role of the mTOR (mammalian target of rapamycin) /S6K1 pathway in breast cancer.
Eating red or white meat, including meat cooked at high temperatures, does not increase the risk of breast cancer in postmenopausal women, according to a large study conducted by researchers at Albert Einstein College of Medicine at Yeshiva University. The study was published this month in the International Journal of Cancer.
Scientists at Albert Einstein College of Medicine of Yeshiva University have previously shown that the co-mingling of three cell types can predict whether localized breast cancer will spread throughout the body. Now, a collaborative study led by investigators at New York-Presbyterian Hospital/Weill Cornell Medical Center has produced a test for metastasis that could help doctors precisely identify which patients should receive aggressive therapy.
Yeshiva College and Stern College for Women professors will tackle male infertility, breast cancer, and supercritical fluids as recipients of three substantial science grants totaling close to half a million dollars.